학술논문

Morquio A Syndrome‐Associated Mutations: A Review of Alterations in the GALNS Gene and a New Locus‐Specific Database
Document Type
article
Source
Human Mutation. 35(11)
Subject
Biological Sciences
Biomedical and Clinical Sciences
Genetics
Rare Diseases
Alleles
Animals
Biomarkers
Chondroitinsulfatases
Databases
Nucleic Acid
Disease Models
Animal
Gene Frequency
Genetic Association Studies
Genotype
Geography
Humans
Infant
Newborn
Mucopolysaccharidosis IV
Mutation
Neonatal Screening
Phenotype
Quantitative Trait Loci
MPS IVA
Morquio A
mucopolysaccharidosis type IVA
GALNS
lysosomal storage disorder
Clinical Sciences
Genetics & Heredity
Clinical sciences
Language
Abstract
Morquio A syndrome (mucopolysaccharidosis IVA) is an autosomal recessive disorder that results from deficient activity of the enzyme N-acetylgalactosamine-6-sulfatase (GALNS) due to alterations in the GALNS gene, which causes major skeletal and connective tissue abnormalities and effects on multiple organ systems. The GALNS alterations associated with Morquio A are numerous and heterogeneous, and new alterations are continuously identified. To aid detection and interpretation of GALNS alterations, from previously published research, we provide a comprehensive and up-to-date listing of 277 unique GALNS alterations associated with Morquio A identified from 1,091 published GALNS alleles. In agreement with previous findings, most reported GALNS alterations are missense changes and even the most frequent alterations are relatively uncommon. We found that 48% of patients are assessed as homozygous for a GALNS alteration, 39% are assessed as heterozygous for two identified GALNS alterations, and in 13% of patients only one GALNS alteration is detected. We report here the creation of a locus-specific database for the GALNS gene (http://galns.mutdb.org/) that catalogs all reported alterations in GALNS to date. We highlight the challenges both in alteration detection and genotype-phenotype interpretation caused in part by the heterogeneity of GALNS alterations and provide recommendations for molecular testing of GALNS.